According to T2 Biosystems 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.6177. At the end of 2023 the company had a P/S ratio of 3.53.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.53 | 658.31% |
2022 | 0.4660 | -84.74% |
2021 | 3.05 | -69.83% |
2020 | 10.1 | 42.33% |
2019 | 7.11 | -43.85% |
2018 | 12.7 | -59.97% |
2017 | 31.6 | -19.39% |
2016 | 39.2 | -58.28% |
2015 | 94.1 | -97.1% |
2014 | > 1000 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Aldeyra Therapeutics
ALDX | N/A | N/A | ๐บ๐ธ USA |
CareDx CDNA | 2.75 | -74.14% | ๐บ๐ธ USA |